Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 2/20/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mike Macnamee?

Mike Macnamee

Vice President and Head

Pre-Clinical Development

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Pre-Clinical Development

Background Information

Employment History

PEMCF


Chief Executive Officer

BHI


Chief Executive Officer

UK Lets Do ICSI 03rd


Children's Health Hospital


Chief Executive Officer

Bourn Hall Clinic Limited


Affiliations

Obstetrics and Gynaecology Equipment

Moderator


Education

BSc


MSc


PhD


Web References(129 Total References)


Directors Biographies | Bourn Hall Clinic

www.bourn-hall-clinic.co.uk [cached]

Mike Macnamee, BSc,MSc,PhD
Chief Executive Mike Macnamee, BSc,MSc,PhD has over 20 years scientific and management experience in the field of infertility, rising through clinical embryology/endocrinology to replace Professor Robert Edwards as Scientific Director of Bourn Hall Clinic in 1991 and to General Manager in 2000; he has worked internationally in the research of reproductive drug development with over 60 peer reviewed published papers. Mike has extensive experience of giving both technical lectures and non-technical presentations to a broad range of audiences at worldwide conferences. By 2002 Mike had been promoted to Vice President and Head of Pre-Clinical Development within the Serono organisation. At the end of 2005, as Chief Executive, Mike's commitment to Bourn Hall's future was demonstrated by his leadership of the Management Buy-Out team in achieving successful independence from its previous pharmaceutical parent.


Bourn Hall management team secures buy-out from Serono | PEM Corporate Finance

www.pem.co.uk [cached]

Mike Macnamee, Chief Executive of Bourn Hall Limited, commented:
This agreement represents an exciting opportunity for the committed management team at Bourn Hall to focus on the organisation's core strengths and develop or extend these further. Our people have a unique understanding of the requirements of our patients, partners and customers and we believe that being an independent company gives us the flexibility to further expand, improve and enhance our service delivery. The deal enables the dedicated management team, all of whom have held senior positions at the organisation for over 10 years, to shape the future growth and development of this internationally renowned company. Led by Mike Macnamee, BSc, MSc, PhD, Chief Executive, the management team comprises Simon Barton ACMA, Finance Director; Nicola Graver FCIPD, Human Resources Director, Lisa Gibbons RGN, Clinical Research Director and Dawn Wilkerson, IT and Core Services Director. Mike Macnamee went on to say: We were delighted to be Lead Advisers to the transaction, working closely with Mike and his team from the outset to completion, and to have successfully concluded the deal to such a tight timetable.


PEMCF | Deals advised on by PEMCF | MBO of Bourn Bioscience

www.pemcf.com [cached]

Mike Macnamee


Bourn Hall Clinic buys ISIS Fertility | PEM Corporate Finance

www.pem.co.uk [cached]

In 2005, Mike Macnamee led a management buyout from Bourn Hall's Swiss pharmaceutical parent company Serono.


Raising investment finance for Bourn Hall Clinic | PEM Corporate Finance

www.pem.co.uk [cached]

Mike Macnamee, Chief Executive of Bourn Hall, said:
We are pleased to have helped Bourn Hall with this fund raising. We advised on the original buyout of the business from Serono, and the subsequent acquisition of ISIS fertility in 2009, so it has been a pleasure to work with Mike and his team once again.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory